| Karis M Mccarroll, MD PA | |
|
16110 Via Shavano, San Antonio, TX 78249-2380 | |
| (210) 615-7171 | |
| (210) 615-6793 |
| Full Name | Karis M Mccarroll |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 41 Years |
| Location | 16110 Via Shavano, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144291519 | NPI | - | NPPES |
| 1144291519 | Other | TX | NPI |
| 097574002 | Medicaid | TX | |
| 240007915 | Other | TX | RAILROAD MEDICARE NUMBER |
| G5032 | Other | TX | TEXAS LICENSE |
| 00B79C | Other | TX | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | G5032 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stephen Miller Md, Pa | 6800837659 | 10 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced plans to initiate a Phase 2 proof-of-concept clinical trial in the second half of 2010 to evaluate the effectiveness and safety of its oncology drug candidate bafetinib (formerly known as INNO-406) in patients with an advanced form of prostate cancer known as metastatic hormone-refractory prostate cancer.
The technical name of the vaccine is ChAdOx1 nCoV-19 (AZD1222), as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus). The vaccine has been engineered to express the SARS-CoV-2 spike protein.
Bethesda, MD-A group of really brainy scientists have moved closer to growing "therapeutic" brain cells in the laboratory that can be re-integrated back into patients' brains to treat a wide range of neurological conditions.
Northrop Grumman Corporation has been selected by the Centers for Disease Control and Prevention (CDC) to compete for task orders to provide information management and technology services in support of the CDC's global health mission under a $5 billion indefinite delivery, indefinite quantity contract.
Collaborations between Johns Hopkins and National Taiwan University researchers have successfully manipulated the life span of common, single-celled yeast organisms by figuring out how to remove and restore protein functions related to yeast aging.
› Verified 2 days ago
| Entity Name | Stephen Miller Md, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073584421 PECOS PAC ID: 6800837659 Enrollment ID: O20050521000104 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced plans to initiate a Phase 2 proof-of-concept clinical trial in the second half of 2010 to evaluate the effectiveness and safety of its oncology drug candidate bafetinib (formerly known as INNO-406) in patients with an advanced form of prostate cancer known as metastatic hormone-refractory prostate cancer.
The technical name of the vaccine is ChAdOx1 nCoV-19 (AZD1222), as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus). The vaccine has been engineered to express the SARS-CoV-2 spike protein.
Bethesda, MD-A group of really brainy scientists have moved closer to growing "therapeutic" brain cells in the laboratory that can be re-integrated back into patients' brains to treat a wide range of neurological conditions.
Northrop Grumman Corporation has been selected by the Centers for Disease Control and Prevention (CDC) to compete for task orders to provide information management and technology services in support of the CDC's global health mission under a $5 billion indefinite delivery, indefinite quantity contract.
Collaborations between Johns Hopkins and National Taiwan University researchers have successfully manipulated the life span of common, single-celled yeast organisms by figuring out how to remove and restore protein functions related to yeast aging.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karis M Mccarroll, MD PA 16110 Via Shavano, San Antonio, TX 78249-2380 Ph: (210) 615-7171 | Karis M Mccarroll, MD PA 16110 Via Shavano, San Antonio, TX 78249-2380 Ph: (210) 615-7171 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced plans to initiate a Phase 2 proof-of-concept clinical trial in the second half of 2010 to evaluate the effectiveness and safety of its oncology drug candidate bafetinib (formerly known as INNO-406) in patients with an advanced form of prostate cancer known as metastatic hormone-refractory prostate cancer.
The technical name of the vaccine is ChAdOx1 nCoV-19 (AZD1222), as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus). The vaccine has been engineered to express the SARS-CoV-2 spike protein.
Bethesda, MD-A group of really brainy scientists have moved closer to growing "therapeutic" brain cells in the laboratory that can be re-integrated back into patients' brains to treat a wide range of neurological conditions.
Northrop Grumman Corporation has been selected by the Centers for Disease Control and Prevention (CDC) to compete for task orders to provide information management and technology services in support of the CDC's global health mission under a $5 billion indefinite delivery, indefinite quantity contract.
Collaborations between Johns Hopkins and National Taiwan University researchers have successfully manipulated the life span of common, single-celled yeast organisms by figuring out how to remove and restore protein functions related to yeast aging.
› Verified 2 days ago
Dr. Robert Jay Magnon, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1303 Mccullough Ave, Suite 525, San Antonio, TX 78212 Phone: 210-225-2769 Fax: 210-225-7576 | |
Dr. Robert Lee Ochs, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 14855 Blanco Rd, Ste 214, San Antonio, TX 78216 Phone: 210-493-1568 Fax: 210-493-8345 | |
Mrs. Terri J Taylor, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7434 Louis Pasteur, Ste 220, San Antonio, TX 78229 Phone: 210-615-9494 Fax: 210-615-1514 | |
Dr. Elizabeth Hughes Tichy, MD Dermatology Medicare: Medicare Enrolled Practice Location: 6712 N New Braunfels Ave, San Antonio, TX 78209 Phone: 210-617-5585 Fax: 210-617-5594 | |
Dr. Patricia Miller Castaneda, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1122 Austin Hwy, San Antonio, TX 78209 Phone: 210-342-6488 | |
Dr. Chantal Barland Devillena, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 18540 Sigma Rd, San Antonio, TX 78258 Phone: 210-490-4661 Fax: 210-490-4661 | |
Rinna C Johnson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7832 Pat Booker Rd., San Antonio, TX 78233 Phone: 210-657-9338 Fax: 210-293-1843 |